Published in TB and Outbreaks Week, July 22nd, 1996
"The discovery of long-lasting rifamycins created the possibility of intermittent drug regimens as has been shown in a number of observations with rifapentine, which accumulates to higher concentrations than does rifampin in macrophages," researcher Natan Mor and colleagues wrote...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week